Advertisement
News
Advertisement

Spencer Pharmaceutical adds Buschmann to science board

Tue, 12/28/2010 - 8:37am
Mass High Tech: The Journal of New England Technology

Spencer Pharmaceutical Inc., a metabolic disease-focused firm in Boston, has appointed Michael Buschmann, director of the FRSQ Group in Biomedical Science and Technology, to Spencer’s scientific advisory board.

According to a news release from the company, Buschmann will  help in advising Spencer in its product development plans and technology licensing plans.

SOURCE

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading